AAAAAA
Results:
1-22
|
Results: 22
Authors:
Mira, Y
Todoli, J
Alonso, R
Mico, ML
Vaya, A
Ferrando, F
Estelles, A
Villa, P
Aznar, J
Citation: Y. Mira et al., Factor V Leiden and prothrombin G20210A in relation to arterial and/or vein rethrombosis: Two cases, CL APPL T-H, 7(3), 2001, pp. 234-237
Authors:
Vaya, A
Todoli, J
Ricart, J
Estelles, A
Mira, Y
Villa, P
Calabuig, JR
Aznar, J
Citation: A. Vaya et al., Upper extremity deep vein thrombosis in a young patient double heterozygous for factor V Leiden and prothrombin G20210A mutation, CL APPL T-H, 7(1), 2001, pp. 72-74
Authors:
Falco, C
Tormo, G
Estelles, A
Espana, F
Tormo, E
Gilabert, J
Velasco, JA
Aznar, J
Citation: C. Falco et al., Fibrinolysis and lipoprotein(a) in women with coronary artery disease. Influence of hormone replacement therapy, HAEMATOLOG, 86(1), 2001, pp. 92-98
Authors:
Estelles, A
Dalmou, J
Falco, C
Berbel, O
Castello, R
Espana, F
Aznar, J
Citation: A. Estelles et al., Plasma PAI-1 levels in obese children - Effect of weight loss and influence of PAI-1 promoter 4G/5G genotype, THROMB HAEM, 86(2), 2001, pp. 647-652
Authors:
Vaya, A
Garcia, M
Mira, Y
Ferrando, F
Villa, P
Estelles, A
Aznar, J
Citation: A. Vaya et al., Homozygous 20210G/A prothrombin gene mutation associated with bilateral iliac vein thrombosis: A case report, THROMB RES, 104(4), 2001, pp. 293-296
Authors:
Blakely, BT
Rossi, FMV
Tillotson, B
Palmer, M
Estelles, A
Blau, HM
Citation: Bt. Blakely et al., Epidermal growth factor receptor dimerization monitored in live cells, NAT BIOTECH, 18(2), 2000, pp. 218-222
Congenital and acquired thrombotic risk factors in women using oral contraceptives: Clinical aspects
Authors:
Mira, Y
Aznar, J
Estelles, A
Citation: Y. Mira et al., Congenital and acquired thrombotic risk factors in women using oral contraceptives: Clinical aspects, CL APPL T-H, 6(3), 2000, pp. 162-168
Authors:
Mira, Y
del Castillo, GG
Estelles, A
Villa, P
Vaya, A
Ortuno, C
Aznar, J
Citation: Y. Mira et al., Portal vein thrombosis associated to prothrombin G20210A mutation and protein C deficiency, CL APPL T-H, 6(3), 2000, pp. 179-180
Authors:
Vaya, A
Trenor, R
Molla, S
Estelles, A
Mira, Y
Villa, P
Aznar, J
Citation: A. Vaya et al., Acute myocardial infarction associated with the prothrombin G20210A mutation, CL APPL T-H, 6(2), 2000, pp. 111-112
Authors:
Vaya, A
Forner, MJ
Estelles, A
Villa, P
Mira, Y
Ferrando, F
Fuster, MJG
Oliver, V
Aznar, J
Citation: A. Vaya et al., Intracardiac thrombosis in a case of Behcet's disease associated with the prothrombin 20210G-A mutation, HAEMATOLOG, 85(4), 2000, pp. 425-428
Authors:
Aznar, J
Vaya, A
Estelles, A
Mira, Y
Segui, R
Villa, P
Citation: J. Aznar et al., Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives, HAEMATOLOG, 85(12), 2000, pp. 1271-1276
Authors:
Estelles, A
Villa, P
Mira, Y
Vaya, A
Segui, R
Aznar, J
Citation: A. Estelles et al., Factor V Leiden in absence of activated protein C resistance after orthotopic liver transplantation in a patient without thrombosis but with familialthrombophilia, HAEMATOLOG, 85(1), 2000, pp. 111-112
Authors:
Martinez, M
Espana, F
Royo, M
Vera, CD
Estelles, A
Jimenez-Cruz, JF
Medina, P
Aznar, J
Citation: M. Martinez et al., Prostate-specific antigen complexed to alpha(1)-antichymotrypsin in the early detection of prostate cancer, EUR UROL, 38(1), 2000, pp. 85-90
Authors:
Segui, R
Estelles, A
Mira, Y
Espana, F
Villa, P
Falco, C
Vaya, A
Grancha, S
Ferrando, F
Aznar, J
Citation: R. Segui et al., PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects, BR J HAEM, 111(1), 2000, pp. 122-128
Authors:
Vaya, A
Lopez, JM
Mira, Y
Ricart, JM
Villa, P
Espana-Gregori, E
Estelles, A
Aznar, J
Citation: A. Vaya et al., Central retinal vein thrombosis associated with prothrombin 20210G/A gene variant, CL APPL T-H, 5(3), 1999, pp. 190-191
Authors:
Espana, F
Villa, P
Mira, Y
Grancha, S
Royo, M
Estelles, A
Vaya, A
Aznar, J
Citation: F. Espana et al., Factor V Leiden and antibodies against phospholipids and protein S in a young woman with recurrent thromboses and abortion, HAEMATOLOG, 84(1), 1999, pp. 80-84
Authors:
Villa, P
Aznar, J
Vaya, A
Espana, F
Ferrando, F
Mira, Y
Estelles, A
Citation: P. Villa et al., Hereditary homozygous heparin cofactor II deficiency and the risk of developing venous thrombosis, THROMB HAEM, 82(3), 1999, pp. 1011-1014
Authors:
Grancha, S
Estelles, A
Tormo, G
Falco, C
Gilabert, J
Espana, F
Cano, A
Segui, R
Aznar, J
Citation: S. Grancha et al., Plasminogen activator inhibitor-1 (PAI-1) promoter 4G/5G genotype and increased PAI-1 circulating levels in postmenopausal women with coronary arterydisease - Influence of hormone replacement therapy, THROMB HAEM, 81(4), 1999, pp. 516-521
Authors:
Estelles, A
Cano, A
Falco, C
Espana, F
Gilabert, J
Grancha, S
Aznar, J
Citation: A. Estelles et al., Lipoprotein(a) levels and isoforms and fibrinolytic activity in postmenopause - Influence of hormone replacement therapy, THROMB HAEM, 81(1), 1999, pp. 104-110
Authors:
Espana, F
Sanchez-Cuenca, J
Fernandez, PJ
Gilabert, J
Romeu, A
Estelles, A
Royo, M
Muller, CH
Citation: F. Espana et al., Inhibition of human sperm-zona-free hamster oocyte binding and penetrationby protein C inhibitor, ANDROLOGIA, 31(4), 1999, pp. 217-223
Authors:
Espana, F
Royo, M
Martinez, M
Enguidanos, MJ
Vera, CD
Estelles, A
Aznar, J
Jimenez-Cruz, JF
Heeb, MJ
Citation: F. Espana et al., Free and complexed prostate specific antigen in the differentiation of benign prostatic hyperplasia and prostate cancer: Studies in serum and plasma samples - Reply, J UROL, 162(2), 1999, pp. 503-503
Authors:
Estelles, A
Charlton, CA
Blau, HM
Citation: A. Estelles et al., The phosphoprotein protein PEA-15 inhibits Fas- but increases TNF-R1-mediated caspase-8 activity and apoptosis, DEVELOP BIO, 216(1), 1999, pp. 16-28
Risultati:
1-22
|